Dr. Kenneth Ward
Dr. Ward is a board certified obstetrician/gynecologist with specialized training and certification in perinatology. He is one of the few OB-GYN physicians in the country who is also board certified in clinical genetics and molecular genetics. He established the University of Utah’s DNA Diagnostic Testing Laboratory in 1988 in connection with his research into the genetics of birth defects and obstetrical problems, and served as an Investigator for the Eccles Program in Human Molecular Biology and Genetics. After his residency in OB-GYN at George Washington University in 1987, he completed a fellowship in Maternal-Fetal Medicine and Medical Genetics at the University of Utah. Prior to devoting his full-time efforts to genetic research, Dr. Ward was Professor and Department Chair of the OB-GYN department at a major state university hospital and Medical School. He currently heads research at a major biotech company, and serves as Laboratory Director of the CLIA lab at Affiliated Genetics.
Managing Director, Intel
Mark Yahiro is Managing Director, New Business for Intel’s Perceptual Computing Group. His group’s focus is to add senses and human-like interactions to drones, robotics, virtual reality and other new markets. In his position, Mark is responsible for all strategic business initiatives including new business models, licensing, investment, and M&A. Mark brings over 20 years experience in product planning and management, business development, and strategic partnerships and investments for both public and private companies including Intel, PureDepth, Pulse, Hitachi, and various start-ups. He received his MBA in International Business from DePaul University, earned his Software Engineering degree from the University of Illinois and attended the Art Institute of Chicago.
Douglas L. Brutlag, Ph.D.
Professor Emeritus of Biochemistry & Medicine at the Stanford University School of Medicine
Dr. Brutlag received his Ph.D. with Great Distinction from Stanford University in 1972 and has been a Professor of Biochemistry there since 1974. His research helped develop the field of bioinformatics, the application of computer science to molecular biology. In 1979 he was a co-founder of IntelliGenetics, one of the first firms involved in bioinformatics and in 1997 he co-founded the International Society for Computational Biology. He has served on the scientific advisory boards of many firms and organizations including the National Library of Medicine and the Max Planck Institute. Dr. Brutlag’s honors include an NIH Senior Fogarty Fellowship, Fellow of the American Association for the Advancement of Science, Fellow of the American College of Medical Informatics and Honorary Professor of Bioinformatics at Keio University, Japan. He was awarded the 1992 Computerworld-Smithsonian award in science.
Dr. Xiaoyan Sheng
Research Associate, The Scripps Research Institute
Dr. Sheng is a molecular biology and biochemistry scientist. Her focus is metabolism, immunology and neuroscience and finding ways to improve human healthcare, disease prevention and treatment. She holds two drug patents related to the treatment of metabolic disease. She graduated from Nankai University and received her Ph.D. from Shanghai Institute of Biological Sciences, Chinese Academy of Sciences. She completed her first post-doctorate at the National Institute of Health, and her second post-doctorate at The Scripps Research Institute.